相关实验视频

Updated: Jul 15, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

用血管激素II受体阻断剂预防性治疗偏头痛:一种随机对照试验

Erling Tronvik1, Lars J Stovner, Grethe Helde

  • 1Department of Neurology and Clinical Neurophysiology, Norwegian University of Science and Technology, Trondheim, Norway. Erling.Tronvik@medisin.ntnu.no

JAMA
|December 31, 2002
PubMed
概括

坎德沙坦是一种血管激素II受体阻断剂,在安慰剂对照研究中有效减少了头痛天数和偏头痛频率. 这种药物为偏头痛预防提供了耐受性良好的选择,改善了患者的治疗结果.

更多相关视频

Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis06:14

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis

Published on: January 12, 2024

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...